Company profile
Phoenix DX Ltd
Hand-Held PCR Tests | UK | Phoenix DX
Phoenix DX are the UK-based creators of Molerumi, a device for performing hand-held PCR tests. Find out more about our innovative new product.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzNTY0MjI5MmFkaXF6a2N4 | Paper/PDF filed
Published 21 Sep 2024 06:28
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Feasibility assessment of rapid identification (R-ID) technology for point of care detection of urinary tract infections and drug-resistance markers
1 Nov 2018 to 31 Oct 2019
"The proposed project aims to evaluate the technical, clinical, and commercial value of LIG Biowise's developed technology (R-ID) to assist diagnosis and management of urine tract infections (UTI) at the point of care (POC), where high proportion of UTI affected patients is treated. Urinary tract infections (UTI) are very common infections, affecting arou...
Respiratory Infection Detection (R-ID) assay
1 Aug 2017 to 31 Jul 2018
Infectious diseases are one of the major causes of global morbidity and mortality, resulting in 16.2% of deaths per year. Currently, there is no fast diagnostic tool available to detect and identify the different pathogens responsible for the most common infections, which leads to unnecessary prescription of antibiotics and the subsequent development of d...
Magnetic Antimicrobial Peptide-based (MAP) DNA Extraction Kit
1 Jun 2017 to 31 May 2018
The accuracy and sensitivity of a molecular diagnostic method is dependent of the efficient extraction of nucleic acids and absence of amplification inhibitors in the reaction mixture. Bacterial DNA/RNA extraction usually requires enzymatic, physical or chemical cell lysis, which is especially critical when working with Gram + bacteria. DNA/RNA purificati...
Spiky Ag Nanoparticles for Super-Efficient Antibacterial Surface Coatings
1 Apr 2016 to 31 Jul 2016
Silver (Ag) nanoparticles have gained popularity for use in medical devices, washing powders and water treatments largely due to the emergence of resistant bacteria (superbugs) and the resultant reduction in the effective number of available treatments. However concerns have been raised due to the high concentrations required including the lack of availab...
Biodegradable Antibacterial Nanoparticles: The Next Generation of Antibiotics
1 Sep 2015 to 31 Dec 2015
Nosocomial infections caused by multidrug-resistant microorganisms such as MRSA and P.aeruginosa are observed frequently in hospital settings; resulting in serious public health problems. The most pressing concern is that they are becoming resistant to almost all antibiotics available at the present time. Nanomedicine offers new possibilities including fe...